Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1923]

Repurposing generics to fight cancer and the work of the ReDO Project

Dr Gauthier Bouche - Anticancer Fund, Strombeek-Bever, Belgium

Repurposing generics to fight cancer and the work of the ReDO Project ( Dr Gauthier Bouche - Anticancer Fund, Strombeek-Bever, Belgium )

Continual low-dose metronomic chemotherapy as potentially preferable to...

Prof Yuval Shaked - Israel Institute of Technology, Haifa, Israel

Continual low-dose metronomic chemotherapy as potentially preferable to aggressive strategies ( Prof Yuval Shaked - Israel Institute of Technology, Haifa, Israel )

New metronomic approach to neuroblastoma

Prof Frank Berthold - University Hospital Köln, Köln, Germany

New metronomic approach to neuroblastoma ( Prof Frank Berthold - University Hospital Köln, Köln, Germany )

Cost-effectiveness of metronomic approach to neuroblastoma and its use in...

Dr Jaroslav Sterba - University Children’s Hospital Brno, Brno, Czech Republic

Cost-effectiveness of metronomic approach to neuroblastoma and its use in combination with other therapies ( Dr Jaroslav Sterba - University Children’s Hospital Brno, Brno, Czech Republic )

Advances in multiple myeloma: Expert panel discussion

Prof Pieter Sonneveld; Prof Antonio Palumbo; Prof Marivi Mateos; Prof Meletios...

Advances in multiple myeloma: Expert panel discussion ( Prof Pieter Sonneveld; Prof Antonio Palumbo; Prof Marivi Mateos; Prof Meletios Dimopoulos )

Industry view of targeted therapy combinations in oncology

Dr Susan Galbraith – AstraZeneca, Macclesfield, UK

Industry view of targeted therapy combinations in oncology ( Dr Susan Galbraith – AstraZeneca, Macclesfield, UK )

Genomic complexity of metastatic disease and the conundrum of combinations

Prof Razelle Kurzrock - University of California, San Diego, USA

Genomic complexity of metastatic disease and the conundrum of combinations ( Prof Razelle Kurzrock - University of California, San Diego, USA )

Complexity of intra- and inter-pathway loops in colon cancer and melanoma:...

Prof René Bernards - Netherlands Cancer Institute, Amsterdam, The Netherlands

Complexity of intra- and inter-pathway loops in colon cancer and melanoma: Implications for targeted therapies ( Prof René Bernards - Netherlands Cancer Institute, Amsterdam, The Netherlands )

WIN consortium as a basis for forming cross-border collaborations for improving...

Dr Oliver Bogler - MD Anderson Cancer Center, Houston, USA

WIN consortium as a basis for forming cross-border collaborations for improving personalised medicine and palliative care ( Dr Oliver Bogler - MD Anderson Cancer Center, Houston, USA )

Work of the WIN consortium and challenges of personalised cancer therapy

Prof John Mendelsohn - University of Texas MD Anderson Cancer Center, Houston...

Work of the WIN consortium and challenges of personalised cancer therapy ( Prof John Mendelsohn - University of Texas MD Anderson Cancer Center, Houston, USA )

Tumour-infiltrating immune cells as classifiers and predictors of outcome

Dr Jérôme Galon - Laboratory of Integrative Cancer Immunology, Paris, France

Tumour-infiltrating immune cells as classifiers and predictors of outcome ( Dr Jérôme Galon - Laboratory of Integrative Cancer Immunology, Paris, France )

Molecular investigations of immune cells and tumour environment: The ovarian...

Dr George Coukos - Ludwig Center for Cancer Research, Epalinges, Switzerland

Molecular investigations of immune cells and tumour environment: The ovarian cancer model ( Dr George Coukos - Ludwig Center for Cancer Research, Epalinges, Switzerland )

More from ecancer